Funding
← Back to your selection

Alderline Group

Activity from announced rounds

All recorded activity
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$668M
3 disclosed · full round size, not this investor’s share

By stage

Series C+2
Series A1

By primary sector

Biotech3

By country

United States3

Rounds

3 in all activity
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant
Third Arc Bio

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications

$52MSeries A+
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed